C4 Therapeutics, Inc. (CCCC)

3.85 -6.10% (-0.25)

Over 1Y: +51.0%

2026-08-28
Style
Area Line Line with markers Steps Candlesneeds a shorter window Hollow candlesneeds a shorter window Barsneeds a shorter window

Candles need the day’s open, high and low. Those are being collected now — a company shows them once its history has been refreshed.

2 3 4
Aug Oct Dec Feb Apr Jun Aug

Financials Quarterly

Figures
Revenue Gross Profit Operating Income Cost of Revenue Operating Cash Flow Free Cash Flow Net Income

A share count and earnings a share are not here: neither is money, so neither can share this axis. Both have their own panel on All charts.

All charts ›
Q3 '21 — Revenue: 8.5M Q3 '21 — Operating Cash Flow: -18.4M Q3 '21 — Free Cash Flow: -18.4M Q3 '21 — Net Income: -24.7M Q4 '21 — Revenue: 20.1M Q4 '21 — Operating Cash Flow: -25.7M Q4 '21 — Free Cash Flow: -25.8M Q4 '21 — Net Income: -15.7M Q1 '22 — Revenue: 7.7M Q1 '22 — Operating Cash Flow: -26.6M Q1 '22 — Free Cash Flow: -26.8M Q1 '22 — Net Income: -31.6M Q2 '22 — Revenue: 13.8M Q2 '22 — Operating Cash Flow: -22.2M Q2 '22 — Free Cash Flow: -22.7M Q2 '22 — Net Income: -27.4M Q3 '22 — Revenue: 6.8M Q3 '22 — Operating Cash Flow: -28M Q3 '22 — Free Cash Flow: -31.3M Q3 '22 — Net Income: -32M Q4 '22 — Revenue: 2.9M Q4 '22 — Operating Cash Flow: -29.1M Q4 '22 — Free Cash Flow: -30.6M Q4 '22 — Net Income: -37.2M Q1 '23 — Revenue: 3.8M Q1 '23 — Operating Cash Flow: -33.1M Q1 '23 — Free Cash Flow: -33.7M Q1 '23 — Net Income: -34.8M Q2 '23 — Revenue: 2.7M Q2 '23 — Operating Cash Flow: -19M Q2 '23 — Free Cash Flow: -19.4M Q2 '23 — Net Income: -35.9M Q3 '23 — Revenue: 11.1M Q3 '23 — Operating Cash Flow: -30.7M Q3 '23 — Free Cash Flow: -31.3M Q3 '23 — Net Income: -27M Q4 '23 — Revenue: 3.3M Q4 '23 — Operating Cash Flow: -24M Q4 '23 — Free Cash Flow: -24.2M Q4 '23 — Net Income: -34.8M Q1 '24 — Revenue: 3M Q1 '24 — Operating Cash Flow: -18.1M Q1 '24 — Free Cash Flow: -18.1M Q1 '24 — Net Income: -28.4M Q2 '24 — Revenue: 12M Q2 '24 — Operating Cash Flow: -5M Q2 '24 — Free Cash Flow: -5.2M Q2 '24 — Net Income: -17.7M Q3 '24 — Revenue: 15.4M Q3 '24 — Operating Cash Flow: -24.1M Q3 '24 — Free Cash Flow: -24.1M Q3 '24 — Net Income: -24.7M Q4 '24 — Revenue: 5.2M Q4 '24 — Operating Cash Flow: -17.9M Q4 '24 — Free Cash Flow: -17.9M Q4 '24 — Net Income: -34.6M Q1 '25 — Revenue: 7.2M Q1 '25 — Operating Cash Flow: -33.3M Q1 '25 — Free Cash Flow: -33.3M Q1 '25 — Net Income: -26.3M Q2 '25 — Revenue: 6.5M Q2 '25 — Operating Cash Flow: -12.1M Q2 '25 — Free Cash Flow: -12.2M Q2 '25 — Net Income: -26M Q3 '25 — Revenue: 11.2M Q3 '25 — Operating Cash Flow: -31.2M Q3 '25 — Free Cash Flow: -31.6M Q3 '25 — Net Income: -32.2M Q4 '25 — Revenue: 11M Q4 '25 — Operating Cash Flow: -22.1M Q4 '25 — Free Cash Flow: -22.2M Q4 '25 — Net Income: -20.5M Q1 '26 — Revenue: 6.2M Q1 '26 — Operating Cash Flow: -29.9M Q1 '26 — Free Cash Flow: -30M Q1 '26 — Net Income: -25.1M Q2 '26 — Revenue: 6.6M Q2 '26 — Operating Cash Flow: -1.6M Q2 '26 — Free Cash Flow: -1.6M Q2 '26 — Net Income: -23.6M -30M -15M 0 15M 30M
Q4 '21 Q3 '22 Q2 '23 Q1 '24 Q4 '24 Q3 '25 Q2 '26
Revenue Operating Cash Flow Free Cash Flow Net Income

Figures as at 2026-06-30, reported in USD. The newest fact in the filings is dated 2026-06-30, 61 days ago. Nothing on this page is advice.

How it scores

Five questions, each answered by the measures under it. Every figure is the company's own; the bar beside it is where that figure sits among the companies read here — the top fifth, the bottom fifth, or somewhere between. Not among all listed companies, and for a valuation multiple the low end is the good end.

Quality

How much of the revenue is really kept — and what did it take to earn it?

0.6
SBC / sales 40.8%
OE margin -284.5%
Oper. margin -319.0%
Accruals -4.6%
Asset turnover 0.097×
EBITDA margin -314.8%
FCF margin -243.7%
OCF margin -242.2%
Profit margin -289.4%
ROA -28.2%
ROCE -35.9%
ROE -41.0%
Gross margin —
OCF / EBIT —
ROIC —

4 of 17 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Valuation

What does the price ask for what the company earns, owns and pays out?

0.5
Div. yield —
EV/EBIT —
EV/GP —
EV/OE —
EV/Sales —
FCF yield —
Fwd P/E —
P/B —
P/C —
P/E —
PEG —

0 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Durability

How predictable is the revenue, and how much of it is already committed?

4.5
RPO / sales 0.76×
RPO growth —
Segment HHI —

3 of 7 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Resilience

Can the balance sheet absorb a bad year?

8.0
Current ratio 12.2×
ND/EBITDA —
Cash runway 4.0 yr
Debt / Eq 0.0×
Debt payback 0.0 yr
Quick ratio 5.4×
F-score 3.9 pts
Cash / Debt —
Interest cover —
Payout —

3 of 12 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

Growth

Is the business getting bigger, and is it getting more profitable?

4.7
Sales/sh Y/Y -14.4%
Sales Q/Q +2.8%
Shares change +19.5%
Div. growth —
EBIT CAGR —
EBIT Y/Y —
EPS CAGR 4Y —
EPS Y/Y —
EPS next Y —

4 of 13 counted in the score. The rest are measures this model does not include here, or figures these filings do not carry — switch any of them on and the score changes.

A measure absent from a block could not be computed from this company's filings. It is left out rather than scored as though it were bad, and the dimension is averaged over what remains. A score is measured against a fixed scale this model states; the bar is measured against the other companies, so the two can disagree — and where they do, that disagreement is the more interesting figure.